Max Healthcare Institute Limited has announced the approval of a grant of 2,15,000 stock options to its eligible employees under the Employee Stock Option Scheme 2022. The decision was formalized by the Nomination and Remuneration Committee during their meeting held on May 20, 2026, as part of the company’s commitment to employee incentivization and retention strategies.
Stock Option Grant Details
The Nomination and Remuneration Committee (NRC) met on May 20, 2026, to finalize the allocation of stock options. A total of 2,15,000 options have been granted, divided into two distinct tranches based on different exercise prices. Each option is convertible into one fully paid-up equity share with a face value of ₹10.
Breakdown of Allocation
- Tranche 1: 90,000 stock options granted at an exercise price of ₹350 per option.
- Tranche 2: 1,25,000 stock options granted at an exercise price of ₹800 per option.
Vesting and Exercise Terms
The vesting of these options is subject to the fulfillment of specific pre-vesting conditions determined by the NRC. The vesting period will range between 1 to 5 years from the date of grant. Once vested, employees have a window of 3 years to exercise their options. All granted options are governed by the established MHIL ESOP – 2022 framework, ensuring standardized administration across the organization.
Source: BSE
